Clinical Trial Update: Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy [NA]

View source ↗

Summary

This update reports a completed randomized trial evaluating the combination of beta interferon and thalidomide in patients with adrenoleukodystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenoleukodystrophy

Drugs mentioned

• Beta Interferon (interferon beta)
• Thalidomide (thalidomide)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Adrenoleukodystrophy | NA | Status: COMPLETED